In June 2018, a CBD based drug got the FDA approval to treat epileptic seizures. This post from SOL*CBD delves deeper into what led to this decision & what CBD oil can do for the body. A big change is coming to U.S. federal policy on medical marijuana. For well over a year now, despite the opinions from the current administration, the signs coming out of the Food and ... Continue Reading
childhood epilepsy
GW Pharmaceuticals Reports Positive Results of Epidiolex® Phase 3 Trial
GW Pharmaceuticals reports the results of phase 3 study of Epidiolex for treatment of Dravet syndrome, a rare and severe form of epilepsy. This post from Clinical Leader gives the study overview and discusses the phase 3 trial results. GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, ... Continue Reading
Remarkable CBD Benefits for Childhood Epilepsy
In this post from Sol*CBD, Dr. Carlos Santo creates awareness about CBD and its remarkable benefits for treating childhood epilepsy. Parents of children with epilepsy are at the front line of the scientific debate on the cause and treatment of childhood seizures. While conventional science takes the conservative approach in managing seizure threshold, frequency, and severity, ... Continue Reading